Blueprint Medicines Reports Second Quarter 2022 Results
Go back to Blueprint Medicines Reports Second Quarter 2022 Results| (NASDAQ: BPMC) | Delayed: 129.46 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $129.46 | 52 Week High | $35.96 | |||
| Open | $129.46 | 52 Week Low | $13.04 | |||
| Day High | $129.46 | P/E | N/A | |||
| Day Low | $129.46 | EPS | $0.00 | |||
| Volume | 111,601 | |||||
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 61.31 +0.73 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.58 | 52 Week High | $3.48 | |||
| Open | $60.53 | 52 Week Low | $0.80 | |||
| Day High | $61.60 | P/E | N/A | |||
| Day Low | $60.37 | EPS | $-1.54 | |||
| Volume | 2,325,105 | |||||
